Meet Our Urologists

Sylvia O. Suadicani, PhD

Sylvia O. Suadicani, PhD, Associate Professor of Urology; Assistant Professor of Neurosciences, Urology
Gender: F
Department: Urology
Practice Specialty: Urology
Main Location:
Adult Urology: 718-920-4531
Click here to see our locations

Academic Title: Associate Professor of Urology; Assistant Professor of Neurosciences
Administrative Title: Associate Professor of Urology; Assistant Professor of Neurosciences
Research Focus:

Urogenital Dysfunction in Diabetes, Multiple Sclerosis, Spinal Cord Injury, Estrogen Deficiency, Overactive & Underactive Bladder, Female Sexual Dysfunction; Chronic Pelvic Pain; Interstitial Cystitis; Bladder Cancer


View Dr. Suadicani’s publications on PubMed


Sylvia Suadicani, PhD, is an expert in the area of intracellular and intercellular signaling with a strong background in Cellular Biology, Physiology and Pharmacology. Her research currently focuses on the investigation of mechanisms contributing to development of benign bladder dysfunction, particularly the involvement of pannexin 1 (Panx1) channels and purinergic signaling in the development of diabetic cystopathy, interstitial cystitis, and neurogenic bladder in Multiple Sclerosis and spinal cord injury, as well as mechanisms leading to the development of urologic chronic pelvic pain.

Dr. Suadicani’s general interest and expertise in the pathophysiology of cell signaling has led to collaborations with faculty from other departments at Einstein and abroad. Examples of ongoing collaborations are studies conducted with Dr. Kelvin P. Davies (Department of Urology, Einstein) to better understand mechanisms that underlie development of benign urologic conditions; studies with Dr. David C. Spray (Department of Neuroscience, Einstein) focused on pelvic pain; studies with Dr. Mia M. Thi (Department of Orthopaedic Surgery, Einstein) to investigate the effects of diabetes on bone cell mechanosensing and transduction; and studies with Drs. David J. Sharp (Department of Physiology & Biophysics, Einstein) and Kelvin Davies to identify new targets to treat acute spinal cord injury and associated bladder and erectile dysfunction.